What does Renovaro, Inc. do?
Renovaro, Inc. is a biotechnology company focused on developing vaccines for colorectal cancer and gene therapies for HIV/AIDS, classified as a micro-cap with a market cap of $61.88 million. It currently reports no net sales or profits and has a debt equity ratio of 0.06.
Overview: Renovaro, Inc. is a biotechnology company focused on developing vaccines for colorectal cancer and gene therapies for HIV/AIDS, operating within the Pharmaceuticals & Biotechnology industry and classified as a micro-cap company.Financial Snapshot:
- Most recent Net Sales: Not available
- Most recent Net Profit: 0 Million (Quarterly Results - Mar 2025)
- Market-cap: USD 61.88 Million (Micro Cap)
Key Metrics:
- P/E: NA (Loss Making)
- Industry P/E: NA
- Dividend Yield: 0.00%
- Debt Equity: 0.06
- Return on Equity: -24.90%
- Price to Book: 0.70
Contact Details:
- Address: Century City Medical Plaza, 2080 Century City East LOS ANGELES CA : 90067
- Tel: 1 212 7630184
- Fax: 1 845 8183588
- Website: https://enochianbio.com/
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
